Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
raleigh-durham blog main
3
×
raleigh-durham top stories
clinical trials
fda
national
national top stories
san francisco blog main
san francisco top stories
venture capital
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
aspire capital fund
astrazeneca
auris health
biogen
bluerock therapeutics
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
crispr
david mcnally
deals
deerfield management
detroit blog main
detroit top stories
diagnostics
drugs
durvalumab
What
plans
3
×
cash
sciences
acquisitions
announced
bio
ceo
clearance
collabs
committed
company
covid
crunch
daniel
deal
deploy
didn’t
end
far
fda
fund
gilead
gilead’s
goal
hatteras
help
introduce
investments
ipo
kicking
latest
launches
life
medical
medical’s
medicines
meet
million
month
needs
Language
unset
Current search:
plans
×
biotech
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
